Data / Form D filings / Paulex Bio Inc.
Paulex Bio Inc.: Form D filing
Paulex Bio Inc., a pharmaceuticals company in La Jolla, CA, filed a Form D with the SEC in 2025. The latest, on December 18, 2025, reports $18.5 million sold of a $22.5 million offering to 163 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6083 OAKGATE ROW, La Jolla, CA, 92037
- Phone
- (202) 308-3507
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2071082
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | New notice | $22,500,000 | $18,516,040 | $3,983,960 | 163 | Nov 21, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edgardo Rayo | Director | |
| Mohammad Hayat | Director | |
| Francisco Leon | Director | |
| Sanjuan Miguel | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Paulex Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.